Medical Intensive Care Unit, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.
Department of Anesthesia and Perioperative Care, University of California San Francisco School of Medicine, San Francisco, California.
Am J Respir Crit Care Med. 2020 Aug 1;202(3):361-370. doi: 10.1164/rccm.201910-1911TR.
Endothelial cells (ECs) are vascular, nonconventional immune cells that play a major role in the systemic response after bacterial infection to limit its dissemination. Triggered by exposure to pathogens, microbial toxins, or endogenous danger signals, EC responses are polymorphous, heterogeneous, and multifaceted. During sepsis, ECs shift toward a proapoptotic, proinflammatory, proadhesive, and procoagulant phenotype. In addition, glycocalyx damage and vascular tone dysfunction impair microcirculatory blood flow, leading to organ injury and, potentially, life-threatening organ failure. This review aims to cover the current understanding of the EC adaptive or maladaptive response to acute inflammation or bacterial infection based on compelling recent basic research and therapeutic clinical trials targeting microvascular and endothelial alterations during septic shock.
内皮细胞(ECs)是血管非传统免疫细胞,在细菌感染后的全身反应中发挥主要作用,以限制其传播。内皮细胞的反应是多态性、异质性和多方面的,其受到病原体、微生物毒素或内源性危险信号的刺激。在败血症中,ECs 向促凋亡、促炎、促黏附和促凝表型转变。此外,糖萼损伤和血管张力功能障碍会损害微循环血流,导致器官损伤,并可能导致危及生命的器官衰竭。本综述旨在根据最近引人注目的基础研究和针对感染性休克期间微血管和内皮改变的治疗性临床试验,涵盖对急性炎症或细菌感染时 EC 适应性或失代偿性反应的现有理解。